secwatch.observer — SEC 8-K summary
======================================

Issuer:     Anika Therapeutics, Inc. (ANIK)
CIK:        0000898437
Form:       8-K
Filed at:   2024-02-26T23:59:59+00:00
Accession:  0001171843-24-000972
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Director Jeffery S. Thompson to retire; John B. Henneman appointed Board Chair
------------------------------------------------------------------------------

- Jeffery S. Thompson will retire from Anika's Board at the 2024 Annual Meeting after 13 years.
- John B. Henneman, III, an independent director since 2020, appointed Board Chair effective immediately.
- Thompson's retirement not due to any disagreement with the Company's operations, policies, or practices.
- Board will have seven directors after Thompson's departure; two Class I directors to be elected at Annual Meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/898437/000117184324000972/0001171843-24-000972-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/898437/000117184324000972/f8k_022624.htm
  HTML page:      https://secwatch.observer/filing/0001171843-24-000972

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer